Pricing Log in Create free account

IceCure Medical Ltd. (ICCM) vs Nexalin Technology, Inc. (NXL)

IceCure Medical Ltd. and Nexalin Technology, Inc. are both Medical Devices companies. IceCure Medical Ltd. is the larger, with a market value of $3.6M against $2.6M — 1.4× the size. Nexalin Technology, Inc. grew revenue faster over the last twelve months: 24.3% against −41.1%. IceCure Medical Ltd. has the higher net margin (−570.1% vs −4,138.5%) and the higher return on invested capital (0.00% vs −1,108.8%). Across the 18 metrics below, IceCure Medical Ltd. leads on 11 and Nexalin Technology, Inc. on 7.

Valuation

Metric ICCM NXL Medical Devices median
P/E n/m n/m 23.22
P/S 0.96 7.62 2.34
P/B 0.22 1.09 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA 0.61 n/m 11.54
EV/Sales (3.44) 3.02 2.24
Earnings yield (574.75%) (613.38%) (10.09%)
Free cash flow yield (794.30%) (383.03%) (8.47%)

Profitability

Metric ICCM NXL Medical Devices median
Gross margin 28.13% 86.14% 56.01%
Operating margin (574.61%) (4,201.66%) (15.03%)
Net margin (570.14%) (4,138.49%) (20.40%)
Free cash flow margin 0.00% (2,917.96%) (7.24%)
Return on equity 0.00% (240.25%) (15.32%)
Return on assets 0.00% (187.89%) (19.72%)
Return on invested capital 0.00% (1,108.82%) (10.33%)

Growth

Metric ICCM NXL Medical Devices median
Revenue growth (TTM) (41.07%) 24.26% 8.80%
EPS growth (last fiscal year) 20.00% 39.76% 29.03%
Revenue growth, 5-year CAGR (2.67%) 4.42% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ICCM NXL Medical Devices median
Debt to equity 0.00 0.00 0.07
Current ratio 2.88 1.25 2.50
Net debt to EBITDA 0.60 0.44 0.49

Dividend

Metric ICCM NXL Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric ICCM NXL Medical Devices median
Market cap 3.56m 2.57m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack